Cervical Cancer Screening: A New Era of Self-Testing and HPV Primary Screening
Recent updates to cervical cancer screening guidelines, released in late 2025 by the American Cancer Society (ACS) and endorsed by the Health Resources and Services Administration (HRSA) in January 2026, signal a significant shift in how women approach preventative care. These changes prioritize HPV primary testing and, crucially, expand access through the acceptance of self-collected samples.
The Rise of HPV Primary Testing
For years, the Pap test (cytology) was the cornerstone of cervical cancer screening. However, both the ACS and HRSA now recommend HPV primary testing for women aged 30-65 at average risk. This test specifically identifies high-risk human papillomavirus (hrHPV) types, which cause approximately 70% of cervical cancers. If HPV primary testing isn’t available, co-testing – combining an HPV test with a Pap test – is recommended. The Pap test alone remains an option if neither of those are accessible.
Empowering Patients with Self-Collection
Perhaps the most impactful change is the acceptance of self-collected HPV tests. Traditionally, sample collection required a pelvic exam and clinician involvement. This presented barriers for some individuals, including those with limited access to healthcare or discomfort with traditional exams. Both the ACS and HRSA recognize self-collection as a valid alternative, expanding screening opportunities.
The FDA approved self-collection tests in 2024 and 2025, paving the way for this change. Evidence demonstrates that self-collected samples are as effective as those collected by a clinician.
Navigating the Screening Schedule: What’s Changed?
Screening frequency varies based on the test used and how the sample is collected. Those receiving HPV primary testing or co-testing with provider-collected samples and normal results can wait five years for their next screening. However, individuals who self-collect their HPV samples and receive normal results should be screened again in three years, according to ACS guidelines. This distinction isn’t included in the HRSA recommendations. A normal Pap test alone requires rescreening in three years. Abnormal results will necessitate more frequent monitoring.
Both sets of guidelines suggest screening can finish at age 65 if previous test results have been consistently normal. The ACS specifies a decade of normal results – negative HPV tests at 60 and 65, or three consecutive negative Pap tests, with the last at age 65. HRSA’s guidelines are less specific regarding past results.
Age of Initiation: A Point of Divergence
The ACS recommends initiating screening at age 25, citing the rarity of cervical cancer in younger individuals. HRSA, however, suggests starting with Pap tests every three years between ages 21 and 29, transitioning to HPV primary testing or co-testing at age 30.
The Impact on Access and Insurance Coverage
HRSA’s endorsement carries significant weight with insurance providers. Starting in 2027, most insurance plans will be required to cover all recommended testing options, including follow-up testing, without copays. This removes a substantial financial barrier to preventative care.
Self-collection is poised to broaden screening access beyond traditional gynecological settings. Screening may become available at primary care offices, urgent care clinics, mobile clinics, and even some pharmacies, or through at-home collection kits. This represents particularly beneficial for individuals lacking access to a gynecologist or who experience discomfort with pelvic exams.
Did you know?
Cervical cancer is largely preventable through regular screening and HPV vaccination. Early detection significantly improves treatment outcomes.
FAQ
Q: What is HPV primary testing?
A: It’s a test that specifically looks for high-risk types of HPV that can cause cervical cancer.
Q: Can I collect my own sample at home?
A: Yes, self-collection is now an accepted method for HPV testing.
Q: How often should I get screened?
A: It depends on the test used, how the sample was collected, and your age. Consult with your healthcare provider.
Q: When can I stop getting screened?
A: Generally, at age 65, if you’ve had consistently normal results.
Q: Will my insurance cover these new screening options?
A: Most insurance plans will be required to cover recommended testing and follow-up starting in 2027.
The most important takeaway is that regular cervical cancer screening is vital. If you have any questions about your screening needs or which test is best for you, consult with a healthcare provider.
Pro Tip: Discuss your screening options with your doctor to determine the best approach for your individual health needs and risk factors.
